Impact of the human leucocyte antigen (HLA)-B leader peptide dimorphism and HLA-A expression on outcomes of stem cell transplantation for sickle cell disease

Br J Haematol. 2021 Oct;195(2):e128-e131. doi: 10.1111/bjh.17665. Epub 2021 Aug 2.

Barbara Cappelli^{1

2}, Graziana M Scigliuolo^{1

2}, Wahid Boukouaci³, Hanadi Rafii^{1

2}, Fernanda Volt^{1

2}, Chantal Kenzey^{1

2}, Karina T Maio^{1

4

5}, Christian Chabannon⁶, Selim Corbacioglu⁷, Vanderson Rocha^{1

8}, Annalisa Ruggeri^{1

9}, Eliane Gluckman^{1

2}, Ryad Tamouza^{1

3

10}

¹ Eurocord, Research Institute Saint-Louis (IRSL) EA3518, Université de Paris, Hôpital Saint-Louis, Assistance Publique - Hôpitaux de Paris, Paris, France.
² Monacord, Centre Scientifique de Monaco, Monaco, Principality of Monaco.
³ Laboratoire Neuro-Psychiatrie Translationnelle, Université Paris Est Créteil, INSERM U955, IMRB, Créteil, France.
⁴ Hospital das Clinicas da Faculdade de Medicina da USP, São Paulo, Brazil.
⁵ Insituto Israelita de Ensino e Pesquisa, Hospital Israelita Albert Einstein, São Paulo, Brazil.
⁶ Department of Cancer Biology, Paoli-Calmettes Institute, Inserm CBT 140, Marseille, France.
⁷ University Children's Hospital, Regensburg, Germany.
⁸ Department of Hematology, Clinics Hospital, University of São Paulo Medical School, São Paulo, Brazil.
⁹ Hematology and Bone Marrow Transplant Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
¹⁰ APHP, Hôpital Henri Mondor, Créteil, France.

No abstract available

Publication types